Teva Recalls Divalproex Sodium 250mg Tablets Due to Spec Failures
Teva North America recalls specific lots of Divalproex Sodium Delayed-release Tablets USP, 250 mg, due to failed tablet specifications.
Recall notice
Failed Tablet/Capsule Specifications
Contact the company
What happened, in plain English
Teva North America is recalling Divalproex Sodium Delayed-release Tablets USP, 250 mg, in 100 count bottles. The recall was initiated because the product failed to meet established tablet specifications. The affected units were distributed nationwide and in Puerto Rico. Read more at govinfonow.com/recall/42608-teva-recalls-divalproex-sodium-250mg-tablets-due-to-spec-failures.
Source Summary by GovInfoNow · govinfonow.com/recall/42608-teva-recalls-divalproex-sodium-250mg-tablets-due-to-spec-failures · Updated October 9, 2026 · FDA enforcement record: FDA #D-1449-2016
Cite this page
“Teva Recalls Divalproex Sodium 250mg Tablets Due to Spec Failures.” GovInfoNow, updated October 9, 2026. https://govinfonow.com/recall/42608-teva-recalls-divalproex-sodium-250mg-tablets-due-to-spec-failures. Based on FDA recall #D-1449-2016 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1449-2016%22&limit=1).
Why it’s dangerous
The record states the tablets failed specifications but does not describe the specific nature of the failure or any resulting health risks to consumers.
Who’s affected
Patients who have been prescribed Divalproex Sodium Delayed-release Tablets USP, 250 mg, manufactured by Teva Pharmaceuticals Ind. Ltd. in Israel for Teva Pharmaceuticals USA, Inc.
How to tell if you have this one
Check your medication bottle for the brand name Teva, NDC 0093-7440-01, Lot # 02D163, and an expiration date of 9/2017. The product is a 250 mg delayed-release tablet in a 100 count bottle.
- Brand
Teva- Category
Drug
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide and Puerto Rico” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 8 months after the firm started it.
- Firm started the recall
- FDA classified it Class III
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-1449-2016 (May 18, 2016) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1449-2016 to see it in context.
- Plain-language summary written by qwen3.6:35b-a3b on October 9, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.